5GMG image
Deposition Date 2016-07-14
Release Date 2016-11-02
Last Version Date 2024-10-23
Entry Detail
PDB ID:
5GMG
Title:
Crystal structure of monkey TLR7 in complex with loxoribine and polyU
Biological Source:
Source Organism:
Macaca mulatta (Taxon ID: 9544)
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.25
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Toll-like receptor 7
Gene (Uniprot):TLR7
Mutagens:N167Q,N389Q,N488Q,N799Q
Chain IDs:A, B
Chain Length:817
Number of Molecules:2
Biological Source:Macaca mulatta
Polymer Type:polyribonucleotide
Molecule:RNA (5'-R(P*UP*UP*UP*U)-3')
Chain IDs:C, D
Chain Length:4
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA
Immunity 45 737 748 (2016)
PMID: 27742543 DOI: 10.1016/j.immuni.2016.09.011

Abstact

Toll-like receptor 7 (TLR7) is a single-stranded RNA (ssRNA) sensor in innate immunity and also responds to guanosine and chemical ligands, such as imidazoquinoline compounds. However, TLR7 activation mechanism by these ligands remain largely unknown. Here, we generated crystal structures of three TLR7 complexes, and found that all formed an activated m-shaped dimer with two ligand-binding sites. The first site conserved in TLR7 and TLR8 was used for small ligand-binding essential for its activation. The second site spatially distinct from that of TLR8 was used for a ssRNA-binding that enhanced the affinity of the first-site ligands. The first site preferentially recognized guanosine and the second site specifically bound to uridine moieties in ssRNA. Our structural, biochemical, and mutagenesis studies indicated that TLR7 is a dual receptor for guanosine and uridine-containing ssRNA. Our findings have important implications for understanding of TLR7 function, as well as for therapeutic manipulation of TLR7 activation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures